Home/Filings/4/0001415889-19-001018
4//SEC Filing

Snow David P. 4

Accession 0001415889-19-001018

CIK 0001035354other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:10 PM ET

Size

5.9 KB

Accession

0001415889-19-001018

Insider Transaction Report

Form 4
Period: 2019-09-12
Snow David P.
Chief Business Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-09-12+150,000150,000 total
    Exercise: $6.47Exp: 2029-09-12Common Stock (150,000 underlying)
Footnotes (2)
  • [F1]The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on September 12, 2020, and the remainder vests in twelve equal quarterly installments thereafter.
  • [F2]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1
  • filerCIK 0001652972

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:10 PM ET
Size
5.9 KB